Article
Both anti-TNF and CTLA4 Ig treatments attenuate the disease severity of staphylococcal dermatitis in mice.
PloS one - 1 Jan 2017
Na Manli, Wang Wanzhong, Fei Ying, Josefsson Elisabet, Ali Abukar, Jin Tao
Abstract excerpt
BACKGROUND: RA patients being treated with biologics are known to have an increased risk of infections. We recently demonstrated that both CTLA4 Ig and anti-TNF treatment aggravate systemic Staphylococcus aureus (S. aureus) infection in mice, but with distinct clinical manifestations. However, the effects of CTLA4 Ig and anti-TNF treatments on a local S. aureus infection (e.g., skin infection) might differ from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
